Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-24

Clinical Trial Update: Low-dose Albumin Infusion for the Prevention of Paracentesis Induced Circulatory Dysfunction (PICD), After Large Volume Paracentesis (LVP) in Decompensated Cirrhosis Liver. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial conducted in Bangladesh completed evaluating low-dose albumin infusion to prevent paracentesis-induced circulatory dysfunction after larg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albumin

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Paracentesis-Induced Circulatory Dysfunction | Phase 4 | Status: COMPLETED